Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma

T Mainou-Fowler1, S J Proctor, P R A Taylor

  • 1Department of Haematological Sciences, School of Clinical and Laboratory Sciences, Leech Building, Newcastle upon Tyne, NE2 4HH, UK. tryfonia.mainou-fowler@ncl.ac.uk

Leukemia Research
|December 5, 2003
PubMed

Insights

Patients with Hodgkin lymphoma show increased production of interleukin-4 (IL4) by peripheral blood cells. This heightened IL4 synthesis is linked to a specific T-cell subset, CD3(+)CD8(+).

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Interleukin (IL) 2 and interferon (IFN) gamma production in Hodgkin lymphoma (HL) is documented.
  • Interleukin-4 (IL4) synthesis in HL has not been previously investigated.

Purpose of the Study:

  • To examine IL4 production by peripheral blood (PB) cells in HL patients.
  • To correlate IL4 levels with T-cell sub-populations in HL.

Main Methods:

  • Stimulation of PB cells with phytohaemaglutinin (PHA) for 2 days.
  • Quantification of IL4 levels and analysis of T-cell sub-populations (CD3(+)CD4(+) and CD3(+)CD8(+)).
  • Flow cytometry used to assess cytoplasmic IL4 intensity (relative median fluorescence - RMF).

Main Results:

  • Significantly increased mean IL4 production in HL patients compared to controls.
  • Increased IL4 levels correlated with the proportion of CD3(+)CD8(+) cells, not CD3(+)CD4(+) cells.
  • Higher cytoplasmic IL4 intensity in CD3(+)CD8(+) cells of HL patients.

Conclusions:

  • Hodgkin lymphoma is associated with increased IL4 production by PHA-activated PB lymphocytes.
  • The CD3(+)CD8(+) T-cell population is identified as the likely source of increased IL4 synthesis in HL.